S 16924

Drug Profile

S 16924

Latest Information Update: 11 Dec 2001

Price : $50

At a glance

  • Originator Servier
  • Class Antipsychotics; Anxiolytics
  • Mechanism of Action Dopamine D4 receptor antagonists; Serotonin 1A receptor agonists; Serotonin 2A receptor antagonists; Serotonin 2C receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Schizophrenia

Most Recent Events

  • 11 Dec 2001 No-Development-Reported for Schizophrenia in France (Unknown route)
  • 09 May 2000 Data have been added to the pharmacodynamics section ,,
  • 24 Apr 1996 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top